GlassScriptPhysician profile
Randall S Baker
NPI 1578558672
$5,961.36
in general payments reported to CMS, 2019-2025
13 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.75 · 2020: $101 · 2021: $1,899 · 2022: $2,349 · 2023: $191 · 2024: $140 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967 · Travel and Lodging: $593 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.67 |
| Travel and Lodging | $592.84 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,284.14 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $1,798.03 | 2021 | |
| Tela Bio, INC. | $183.89 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $174.69 | 2020-2025 | Phasix Mesh |
| Acera Surgical, INC. | $168.51 | 2022-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $136.34 | 2024-2025 | Transorb, Signia |
| Integra Lifesciences Corporation | $51.03 | 2020 | |
| Enterra Medical, INC. | $39.21 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $39.01 | 2025 | |
| Allergan, INC. | $35.54 | 2022 | |
| Abbvie INC. | $18.69 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.52 | 2022 | |
| Btg International INC. | $13.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.